News – Page 139 – Endpoints News

Cassava says two senior employees included in federal probes

11 months ago

Takeda to lay off more employees in Massachusetts

11 months ago

FDA says cancer drug cisplatin is no longer in shortage

11 months ago

Corrected: Boehringer Ingelheim, Gubra put a second candidate into the obesity race

11 months ago

UniQure sells Massachusetts manufacturing site to Genezen as it continues to downsize

11 months ago

Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers

11 months ago

Lilly inks radiopharma deal with Radionetics, with rights to buy the biotech

11 months ago

Aerovate plans to lay off nearly all employees after trial failure

11 months ago

Eisai takes over development of ADC after Bristol Myers ends $650M collaboration

11 months ago

Dianthus teases preclinical data for autoimmune drug as it starts clinical trials

11 months ago

Artiva refiles for IPO three years after original plans in a vastly different environment

11 months ago

Alnylam's big Phase 3 win; LGBTQ+ leaders charting paths; Chevron overturned; and more

11 months ago

EMA's CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval

11 months ago

Merck calls ACIP's pneumococcal recommendation a 'missed opportunity,' advocates for expanding age group

11 months ago

Federal grand jury indicts Cassava collaborator for allegedly defrauding NIH

11 months ago

CMS spells out how states can join new cell and gene therapy access pilot

11 months ago

Why the Supreme Court's overrule of Chevron has major implications for the FDA

11 months ago

Inside BARDA's multibillion-dollar effort to fund long-shot biotechs for Covid

11 months ago

Rovi teases acquisition offers for its CDMO unit potentially worth €2B to €3B

11 months ago

J&J details Phase 3 success of autoimmune disease drug, touting broader range than argenx’s Vyvgart

11 months ago

Savara’s $100M offering; New biotech to test Eisai drug in Ph2

11 months ago

FDA rejects Rocket Pharma’s ultra-rare immune disease gene therapy over manufacturing

11 months ago

Autoimmune brain disease startup Arialys gets new leader; Intellia, Arvinas appoint CFOs

11 months ago

Immunology biotech Alumis secures $250M in shrunken IPO

11 months ago

First page Previous page 136 137 138139140 141 142 Next page Last page